Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer
Keywords: حساسیت به سلول هیپوکسیک; Reirradiation; Recurrent head-and-neck cancer; Tirapazamine; Hypoxic cell sensitizer;